↓ Skip to main content
Altmetric
What is this page?
Embed badge
Share
Share on Twitter
Share on Facebook
Share by email
691TiP PYNNACLE phase II trial of rezatapopt (PC14586) in solid tumors with a TP53 Y220C mutation
Overview of attention for article published in Annals of Oncology, September 2024
Altmetric Badge
About this Attention Score
Good Attention Score compared to outputs of the same age (71st percentile)
Mentioned by
blogs
1
blog
Readers on
mendeley
3
Mendeley
Summary
Blogs
So far, Altmetric has seen
1
blog post.
Rezatapopt
New Drug Approvals,
14 Jul 2025
Rezatapopt, PC…
This page shows the
most recent blog posts
that mention this research output.
Click here
to find out how to access more activity.